Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In the SURMOUNT-1 trial studying tirzepatide for weight loss, nausea rates varied by dose
On July 14, 2025, FTC announced a settlement with a telehealth company, NextMed, and its founders following allegations of deceptive and unfair practices related to NextMeds telehealth weight loss programs offering GLP-1 drugs such as Ozempic and Wegovy
Until and unless retatrutide receives regulatory approval, there is no FDA-approved brand price, pharmacy price, cash-pay price, or standard monthly out-of-pocket cost
Presented for research literature review only Joma M et al
Int J Pharmacol Ther Toxicol 28: 235-240, 1990
Tuy nhin, vi mt s hng dn c bn, bn c th d dng to ra i mi hon ho m khng gp nhiu rc ri
US$ 29.70
US$ 22.83
US$ 22.47
US$ 24.87
US$ 26.95
